# A Study Of Ursolic Acid For Primary Sclerosing Cholangitis

> **NCT03216876** · PHASE1 · WITHDRAWN · sponsor: **University of California, Davis**

## Conditions studied

- Primary Sclerosing Cholangitis

## Interventions

- **DRUG:** Ursolic acid

## Key facts

- **NCT ID:** NCT03216876
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-09
- **Primary completion:** 2019-01
- **Final completion:** 2019-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of feasibility
- **Last updated:** 2017-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03216876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03216876, "A Study Of Ursolic Acid For Primary Sclerosing Cholangitis". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03216876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*